OTC Watch

All stocks / GWLL

GOLDENWELL BIOTECH, INC. GWLL

Goldenwell Biotech (GWLL): a late 10-Q notice in May 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated floatLate filing OTCQBOhio, USA
Live quote on OTC Markets

Market listing

Full name
GOLDENWELL BIOTECH INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 12
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$55
Net loss
($296,471)
What it means

It spends more than it earns

Under strain

Customers paid it $55 in the year. It lost $296,471. For every $1 that came in, about $5391.38 went out.

The report says
Cash and cash equivalents
$26,775
Net cash used in operating activities
($22,629)
What it means

It has cash for a while

Steady

It had $26,775 in the bank and used about $1,886 a month. At that pace the money lasts about 14 months unless it borrows or sells more shares.

The report says
Total assets
$36,120
Total liabilities
$379,833
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $36,120. Its debts and unpaid bills add up to $379,833. That is about $10.52 owed for every $1 owned.

What this adds up to

2 of 3 checks show strain. It spends more than it earns. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-09

Estimated float about 99,000,000 shares as of 2026-11-09: 99,000,000 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-05-12

Filed NT 10-Q on 2026-05-12: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-12-31
99.0M
2026-03-31
99.0M
2026-05-28
99.0M
2026-06-28
99.0M
2026-06-30
99.0M
2026-08-11
99.0M
2026-09-30
99.0M
2026-11-09
99.0M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 10-QFORM 10-Q
2026-10-09 8-KFORM 8-K
2026-10-09 3FORM 3
2026-10-09 SCHEDULE 13D
2026-09-29 8-KFORM 8-K
2026-08-14 10-QFORM 10-Q
2026-07-01 10-KFORM 10-K
2026-07-01 10-QFORM 10-Q
2026-06-29 10-Q/AFORM 10-Q/A
2026-06-26 10-Q/AFORM 10-Q/A
2026-06-26 10-Q/AFORM 10-Q/A
2026-05-27 8-KFORM 8-K

Common questions about GWLL

Does GWLL file reports with the SEC?

Yes. Goldenwell Biotech files with the SEC under company number 0001800373. The most recent filing we hold is a 10-Q dated 2026-11-16.

Source record

How many GWLL shares are outstanding?

99,000,000 shares as of 2026-11-09, as reported to the SEC.

Source record

Has GWLL filed reports late?

Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-05-12. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Goldenwell Biotech making money?

Customers paid it $55 in the year. It lost $296,471. For every $1 that came in, about $5391.38 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record